Abstract: The present invention describes cyclic peptide compounds which modulate integrin mediated adhesion. These compounds can inhibit both .beta..sub.1 and .beta..sub.2 mediated adhesion. The invention further relates to therapeutic uses for these compounds in the treatment of adhesion related pathologies.
Type:
Grant
Filed:
October 28, 1996
Date of Patent:
October 13, 1998
Assignee:
Tanabe Seiyaku Co., Ltd.
Inventors:
Thomas J. Lobl, Shiu-Lan Chiang, Wolfgang Scholz, Nancy Delaet, Pina Cardarelli